A sensitive semi-nested reverse transcriptase-polymerase chain reaction (RT
-PCR) amplification was performed to evaluate estrogen receptor-alpha (ER-a
lpha) mRNA expression in prostate cancer cell lines. We demonstrated the pr
esence of wild-type ER-alpha (wt ER-cl) and five ER-rx variants, designated
ER-alphaA, B, C, D, and E, Unlike ER-alphaA and D, ER-alpha B, C, and E we
re not previously reported in normal or cancerous mammalian cells. DNA sequ
encing analysis of these ER-alpha variants revealed the genetic changes to
be either in-frame or out-of-frame deletions. The expression of each ER-alp
ha variant differs significantly depending on the androgen responsiveness,
tumorigenic and metastatic potentials of each prostate cancer cell line. Th
e potential functional significance of ER-alpha variants was assessed in ye
ast two-hybrid and ERE promoter-reporter mammalian transcription assay syst
ems. The results of these studies indicated that none of the ER-alpha varia
nts can form homo- or heterodimers either with wt ER-alpha or among themsel
ves: in vivo, and that these ER-alpha variants have no demonstrable transcr
iptional or dominant-negative activity, as assessed in vitro. (C) 2001 Else
vier Science Ltd. All rights reserved.